Zerai Manna
Overview
Explore the profile of Zerai Manna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rahman S, Sagar D, Hanna R, Lightfoot Y, Mistry P, Smith C, et al.
Ann Rheum Dis
. 2019 May;
78(7):957-966.
PMID: 31040119
Objectives: The presence of proinflammatory low-density granulocytes (LDG) has been demonstrated in autoimmune and infectious diseases. Recently, regulatory neutrophilic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) were identified in systemic lupus erythematosus...
12.
Hasni S, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Joyal E, et al.
Arthritis Rheumatol
. 2019 Jan;
71(7):1135-1140.
PMID: 30597768
Objective: Autoreactive IgE antibodies have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). We hypothesize that omalizumab, a monoclonal antibody binding IgE, may improve SLE activity by reducing...
13.
Wang S, Wang J, Kumar V, Karnell J, Naiman B, Gross P, et al.
Nat Commun
. 2018 May;
9(1):1758.
PMID: 29717110
Although the aetiology of systemic lupus erythematosus (SLE) is unclear, dysregulated B cell responses have been implicated. Here we show that an unusual CD11cT-bet B cell subset, with a unique...
14.
Carlucci P, Purmalek M, Dey A, Temesgen-Oyelakin Y, Sakhardande S, Joshi A, et al.
JCI Insight
. 2018 Apr;
3(8).
PMID: 29669944
Background: Systemic lupus erythematosus (SLE) is associated with enhanced risk of atherosclerotic cardiovascular disease not explained by Framingham risk score (FRS). Immune dysregulation associated to a distinct subset of lupus...
15.
Barrera-Vargas A, Gomez-Martin D, Carmona-Rivera C, Merayo-Chalico J, Torres-Ruiz J, Manna Z, et al.
Ann Rheum Dis
. 2018 Mar;
77(6):944-950.
PMID: 29588275
Objectives: To assess if ubiquitinated proteins potentially present in neutrophil extracellular traps (NETs) can modify cellular responses and induce inflammatory mechanisms in patients with systemic lupus erythematosus (SLE) and healthy...
16.
Banerjee S, Biehl A, Ghaderi-Yeganeh M, Manna Z, Hasni S
Med Res Arch
. 2017 Dec;
5(3).
PMID: 29276769
Background: Infection is common cause of morbidity and mortality in systemic lupus erythematosus (SLE). Our objective was to determine incidence and types of infections, particularly opportunistic infections, in SLE patients...
17.
Smith C, Seto N, Vivekanandan-Giri A, Yuan W, Playford M, Manna Z, et al.
Ann Rheum Dis
. 2016 Aug;
76(3):602-611.
PMID: 27543414
Objectives: Recent evidence indicates that high-density lipoprotein (HDL) exerts vasculoprotective activities by promoting activating transcription factor 3 (ATF3), leading to downregulation of toll-like receptor (TLR)-induced inflammatory responses. Systemic lupus erythematosus...